Suppr超能文献

压力性尿失禁的细胞治疗

Cell Therapy for Stress Urinary Incontinence.

作者信息

Hart Melanie L, Izeta Ander, Herrera-Imbroda Bernardo, Amend Bastian, Brinchmann Jan E

机构信息

1 Clinical Research Group KFO 273, Department of Urology, University of Tübingen , Tübingen, Germany .

2 Tissue Engineering Laboratory, Instituto Biodonostia, Hospital Universitario Donostia , San Sebastian, Spain .

出版信息

Tissue Eng Part B Rev. 2015 Aug;21(4):365-76. doi: 10.1089/ten.TEB.2014.0627. Epub 2015 Apr 22.

Abstract

Urinary incontinence (UI) is the involuntary loss of urine and is a common condition in middle-aged and elderly women and men. Stress urinary incontinence (SUI) is caused by leakage of urine when coughing, sneezing, laughing, lifting, and exercise, even standing leads to increased intra-abdominal pressure. Other types of UI also exist such as urge incontinence (also called overactive bladder), which is a strong and unexpected sudden urge to urinate, mixed forms of UI that result in symptoms of both urge and stress incontinence, and functional incontinence caused by reduced mobility, cognitive impairment, or neuromuscular limitations that impair mobility or dexterity. However, for many SUI patients, there is significant loss of urethral sphincter muscle due to degeneration of tissue, the strain and trauma of pregnancy and childbirth, or injury acquired during surgery. Hence, for individuals with SUI, a cell-based therapeutic approach to regenerate the sphincter muscle offers the advantage of treating the cause rather than the symptoms. We discuss current clinically relevant cell therapy approaches for regeneration of the external urethral sphincter (striated muscle), internal urethral sphincter (smooth muscle), the neuromuscular synapse, and blood supply. The use of mesenchymal stromal/stem cells is a major step in the right direction, but they may not be enough for regeneration of all components of the urethral sphincter. Inclusion of other cell types or biomaterials may also be necessary to enhance integration and survival of the transplanted cells.

摘要

尿失禁(UI)是指尿液不自主地漏出,是中老年女性和男性的常见病症。压力性尿失禁(SUI)是指在咳嗽、打喷嚏、大笑、提重物、运动甚至站立时,由于腹内压升高导致尿液泄漏。还存在其他类型的尿失禁,如急迫性尿失禁(也称为膀胱过度活动症),即强烈且意外的突然排尿冲动,混合型尿失禁会导致急迫性和压力性尿失禁的症状,以及功能性尿失禁,它是由行动不便、认知障碍或神经肌肉限制导致行动能力或灵活性受损引起的。然而,对于许多压力性尿失禁患者来说,由于组织退化、妊娠和分娩的压力及创伤或手术中获得的损伤,尿道括约肌会有明显损失。因此,对于压力性尿失禁患者,基于细胞的治疗方法来再生括约肌具有治疗病因而非症状的优势。我们讨论了目前临床上用于再生尿道外括约肌(横纹肌)、尿道内括约肌(平滑肌)、神经肌肉突触和血液供应的相关细胞治疗方法。间充质基质/干细胞的应用是朝着正确方向迈出的重要一步,但它们可能不足以再生尿道括约肌的所有组成部分。可能还需要加入其他细胞类型或生物材料,以提高移植细胞的整合和存活率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验